SUV39H1 and chronic obstructive pulmonary disease: Therefore, the pharmacological inhibition of SUV39H1 appears to mimic the pattern of COPD inflammation in PBMCs, which supports a pathological role of SUV39H1 reduction in COPD inflammation.